KG
AVNS

Kilter Group’s Avanos Medical AVNS Stock Holding History

Kilter Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99 Buy
+7
New +$94 ﹤0.01% 1516

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Kilter Group's AVNS Position: Q1 2026 in Review

Kilter Group opened a new position in Avanos Medical (AVNS) in Q1 2026: 7 shares worth $99. The stake represents ﹤0.01% of the portfolio and ranks #1516 among its holdings.

257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Kilter Group held 7 shares of Avanos Medical worth $99 as of Q1 2026.
  • Avanos Medical was a new Kilter Group position in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Kilter Group's portfolio in Q1 2026, its #1516 holding.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.